It's not an macro thing. Even if the macro market moves, Ariad will not move proportionately. The company is trapped. High MC, no more access to capital, huge bloated burn and a clueless CEO with a useless board and 20 something VP's like its EFFIN AMGN.
It does have some value in its drugs to someone who has the capital and knows WTF they are doing.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.